The role of natural killer cells and regulatory t cells while aging with human immunodeficiency virus

dc.contributor.authorAbou Hassan, Farouk F.
dc.contributor.authorBou Hamdan, Mirna A.
dc.contributor.authorMelhem, Nada Mohamad
dc.contributor.departmentMedical Laboratory Sciences Program (MLSP)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:36:24Z
dc.date.available2025-01-24T11:36:24Z
dc.date.issued2019
dc.description.abstractCombined antiretroviral therapy (cART) has increased the quality of life of people living with HIV (PLHIV). Consequently, the number of PLHIV >50 years is increasing worldwide. Patients on cART are known to remain in a proinflammatory state. The latter is linked to the development of non-AIDS-related chronic conditions. Although the number of aging PLHIV is increasing, the effect of HIV infection on the process of aging is not fully understood. Understanding the complexity of aging with HIV by investigating the effect of the latter on different components of the innate and adaptive immune systems is important to reduce the impact of these comorbid conditions and improve the quality of life of PLHIV. The role of killer immunoglobulin receptors (KIRs), expressed on the surface of natural killer (NK) cells, and their human leukocyte antigen (HLA) ligands in the clearance, susceptibility to or disease progression following HIV infection is well established. However, data on the effect of KIR-HLA interaction in aging HIV-infected population and the development of non-AIDS-related comorbid conditions are lacking. Moreover, conflicting data exist on the role of regulatory T cells (Tregs) during HIV infection. The purpose of this review is to advance the current knowledge on the role of NK cells and Tregs while aging with HIV infection. © Copyright 2019, Mary Ann Liebert, Inc.
dc.identifier.doihttps://doi.org/10.1089/aid.2019.0134
dc.identifier.eid2-s2.0-85075093057
dc.identifier.pmid31510754
dc.identifier.urihttp://hdl.handle.net/10938/28595
dc.language.isoen
dc.publisherMary Ann Liebert Inc.
dc.relation.ispartofAIDS Research and Human Retroviruses
dc.sourceScopus
dc.subjectAging
dc.subjectHiv
dc.subjectKirs
dc.subjectNk cells
dc.subjectTregs
dc.subjectAnti-hiv agents
dc.subjectDisease progression
dc.subjectHiv infections
dc.subjectHiv-1
dc.subjectHla antigens
dc.subjectHumans
dc.subjectKiller cells, natural
dc.subjectQuality of life
dc.subjectT-lymphocytes, regulatory
dc.subjectAntivirus agent
dc.subjectHla antigen
dc.subjectImmunoglobulin receptor
dc.subjectAnti human immunodeficiency virus agent
dc.subjectAntiretroviral therapy
dc.subjectArticle
dc.subjectCell aging
dc.subjectHla system
dc.subjectHuman
dc.subjectHuman immunodeficiency virus
dc.subjectHuman immunodeficiency virus infection
dc.subjectNatural killer cell
dc.subjectPriority journal
dc.subjectProtein interaction
dc.subjectRegulatory t lymphocyte
dc.subjectDisease exacerbation
dc.subjectHuman immunodeficiency virus 1
dc.subjectImmunology
dc.titleThe role of natural killer cells and regulatory t cells while aging with human immunodeficiency virus
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-3667.pdf
Size:
303.05 KB
Format:
Adobe Portable Document Format